Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium.

Suurmond J, Dorjée AL, Boon MR, Knol EF, Huizinga TW, Toes RE, Schuerwegh AJ.

Arthritis Res Ther. 2011;13(5):R150. doi: 10.1186/ar3466. Epub 2011 Sep 20. Retraction in: Arthritis Res Ther. 2015;17:354.

2.

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjée AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2586-91. doi: 10.1073/pnas.0913054107. Epub 2010 Jan 25. Retraction in: Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345.

3.

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?

van Baarsen LG, Lebre MC, van der Coelen D, Aarrass S, Tang MW, Ramwadhdoebe TH, Gerlag DM, Tak PP.

Arthritis Res Ther. 2014 Aug 22;16(4):426. doi: 10.1186/s13075-014-0426-z.

4.

Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.

Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, Caňete JD, Baeten D.

Arthritis Rheum. 2012 Jan;64(1):99-109. doi: 10.1002/art.33396.

5.

Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.

Nakano S, Mishiro T, Takahara S, Yokoi H, Hamada D, Yukata K, Takata Y, Goto T, Egawa H, Yasuoka S, Furouchi H, Hirasaka K, Nikawa T, Yasui N.

Clin Rheumatol. 2007 Aug;26(8):1284-92. Epub 2007 Jan 5.

PMID:
17205215
6.

Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.

Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP.

Arthritis Rheum. 2009 Sep;60(9):2595-605. doi: 10.1002/art.24754.

7.

Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy.

Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM.

Arthritis Rheum. 1991 Sep;34(9):1116-24.

PMID:
1930330
8.

Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.

Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Brömme D.

Arthritis Rheum. 2002 Mar;46(3):663-74.

9.

Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.

Sprott H, Pap T, Rethage J, Wintersberger W, Gay RE, Bradley LA, Uebelhart D, Gay S.

J Rheumatol. 2000 Oct;27(10):2347-50.

PMID:
11036828
10.

Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis.

Morita Y, Yamamura M, Nishida K, Harada S, Okamoto H, Inoue H, Ohmoto Y, Modlin RL, Makino H.

Arthritis Rheum. 1998 Feb;41(2):306-14.

PMID:
9485089
11.

Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.

Wang F, Xu L, Feng X, Guo D, Tan W, Zhang M.

Arthritis Res Ther. 2012 Oct 19;14(5):R228. doi: 10.1186/ar4067.

12.

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.

Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P.

Arthritis Rheum. 1999 May;42(5):963-70.

13.

Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

Talabot-Ayer D, McKee T, Gindre P, Bas S, Baeten DL, Gabay C, Palmer G.

Joint Bone Spine. 2012 Jan;79(1):32-7. doi: 10.1016/j.jbspin.2011.02.011. Epub 2011 Mar 26.

PMID:
21441054
14.

Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis.

Kan J, Mishima S, Kashiwakura J, Sasaki-Sakamoto T, Seki M, Saito S, Ra C, Tokuhashi Y, Okayama Y.

Allergol Int. 2016 Sep;65 Suppl:S11-6. doi: 10.1016/j.alit.2016.04.007. Epub 2016 May 18.

15.

IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients.

Roşu A, Mărgăritescu C, Stepan A, Muşetescu A, Ene M.

Rom J Morphol Embryol. 2012;53(1):73-80.

16.

Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II.

Lee H, Kashiwakura J, Matsuda A, Watanabe Y, Sakamoto-Sasaki T, Matsumoto K, Hashimoto N, Saito S, Ohmori K, Nagaoka M, Tokuhashi Y, Ra C, Okayama Y.

Arthritis Rheum. 2013 Jan;65(1):109-19. doi: 10.1002/art.37741.

17.

Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes.

Lee SY, Yoon BY, Kim JI, Heo YM, Woo YJ, Park SH, Kim HY, Kim SI, Cho ML.

Immunology. 2014 Mar;141(3):353-61. doi: 10.1111/imm.12196.

19.
20.

Mast cells in the synovium and synovial fluid in osteoarthritis.

Dean G, Hoyland JA, Denton J, Donn RP, Freemont AJ.

Br J Rheumatol. 1993 Aug;32(8):671-5.

PMID:
8348268

Supplemental Content

Support Center